Skip to main content
SpringerLink
Log in

Antimicrobial Resistance of Shigella spp., Typhoid Salmonella and Nontyphoid Salmonella

  • Chapter
Antimicrobial Drug Resistance

Part of the book series: Infectious Disease ((ID))

At the end of the nineteenth century, the two great forms of dysentery were identifi ed: sporadically occurring amoebic dysentery (amoebiasis) and bacillary dysentery (shigellosis) that tended to produce outbreaks of diarrheal disease. Since fi rst identifi ed, Shigella spp. have been shown to be important causes of mortality worldwide and for epidemic strains of S. dysenteriae type 1 (Shiga bacillus) major causes of mortality in tropical endemic regions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kotloff KL, Winickoff JP, Ivanoff B, et al. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull World Health Organ. 1999;77(8):651–666

    PubMed  CAS  Google Scholar 

  2. Mead PS, Slutsker L, Dietz V, et al. Food-related illness and death in the United States. Emerg Infect Dis. 1999;5(5):607–625

    PubMed  CAS  Google Scholar 

  3. Jiang ZD, Lowe B, Verenkar MP, et al. Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay). J Infect Dis. 2002;185(4):497–502

    Article  PubMed  Google Scholar 

  4. Thornton SA, Sherman SS, Farkas T, Zhong W, Torres P, Jiang X. Gastroenteritis in US marines during operation Iraqi freedom. Clin Infect Dis. 2005;40(4):519–525

    Article  PubMed  Google Scholar 

  5. DuPont HL, Levine MM, Hornick RB, Formal SB. Inoculum size in shigellosis and implications for expected mode of transmission. J Infect Dis. 1989;159(6):1126–1128

    PubMed  CAS  Google Scholar 

  6. World Health Organization. The World Health report 1996 — fighting disease, fostering development. World Health Forum. 1997;18(1):1–8

    Google Scholar 

  7. Edelman R, Levine MM. Summary of an international workshop on typhoid fever. Rev Infect Dis. 1986;8(3):329–349

    PubMed  CAS  Google Scholar 

  8. Hornick RB, Greisman SE, Woodward TE, DuPont HL, Dawkins AT, Snyder MJ. Typhoid fever: pathogenesis and immunologic control. N Engl J Med. 1970;283(13):686–691

    PubMed  CAS  Google Scholar 

  9. Haltalin KC, Nelson JD, Hinton LV, Kusmiesz HT, Sladoje M. Comparison of orally absorbable and nonabsorbable antibiotics in shigellosis. A double-blind study with ampicillin and neomycin. J Pediatr. 1968;72(5):708–720

    Article  PubMed  CAS  Google Scholar 

  10. Murray BE. Resistance of Shigella, Salmonella, and other selected enteric pathogens to antimicrobial agents. Rev Infect Dis. 1986;8 Suppl 2:S172–S181

    PubMed  Google Scholar 

  11. Nelson JD, Kusmiesz H, Jackson LH, Woodman E. Trimethoprim—sulfamethoxazole therapy for shigellosis. JAMA. 1976;235(12):1239–1243

    Article  PubMed  CAS  Google Scholar 

  12. Barada FA, Jr, Guerrant RL. Sulfamethoxazole—trimethoprim versus ampicillin in treatment of acute invasive diarrhea in adults. Antimicrob Agents Chemother. 1980;17(6):961–964

    PubMed  Google Scholar 

  13. DuPont HL, Reves RR, Galindo E, Sullivan PS, Wood LV, Mendiola JG. Treatment of travelers' diarrhea with trimethoprim/ sulfamethoxazole and with trimethoprim alone. N Engl J Med. 1982;307(14):841–844

    PubMed  CAS  Google Scholar 

  14. Bennish ML, Salam MA, Hossain MA, et al. Antimicrobial resistance of Shigella isolates in Bangladesh, 1983–1990: increasing frequency of strains multiply resistant to ampicillin, trimeth-oprim—sulfamethoxazole, and nalidixic acid. Clin Infect Dis. 1992;14(5):1055–1060

    PubMed  CAS  Google Scholar 

  15. Salam MA, Dhar U, Khan WA, Bennish ML. Randomised comparison of ciprofloxacin suspension and pivmecillinam for childhood shigellosis. Lancet. 1998;352(9127):522–527

    Article  PubMed  CAS  Google Scholar 

  16. Munshi MH, Sack DA, Haider K, Ahmed ZU, Rahaman MM, Morshed MG. Plasmid-mediated resistance to nalidixic acid in Shigella dysenteriae type 1. Lancet. 1987;2(8556):419–421

    Article  PubMed  CAS  Google Scholar 

  17. Sivapalasingam S, Nelson JM, Joyce K, Hoekstra M, Angulo FJ, Mintz ED. High prevalence of antimicrobial resistance among Shigella isolates in the United States tested by the National Antimicrobial Resistance Monitoring System from 1999 to 2002. Antimicrob Agents Chemother. 2006;50(1):49–54

    Article  PubMed  CAS  Google Scholar 

  18. Talukder KA, Khajanchi BK, Islam MA, et al. Genetic relatedness of ciprofloxacin-resistant Shigella dysenteriae type 1 strains isolated in south Asia. J Antimicrob Chemother. 2004;54(4):730–734

    Article  PubMed  CAS  Google Scholar 

  19. Taneja N. Changing epidemiology of shigellosis and emergence of ciprofloxacin-resistant Shigellae in India. J Clin Microbiol. 2007;45(2):678–679

    Article  PubMed  Google Scholar 

  20. Talukder KA, Khajanchi BK, Islam MA, et al. The emerging strains of Shigella dysenteriae type 2 in Bangladesh are clonal. Epidemiol Infect. 2006;134(6):1249–1256

    Article  PubMed  CAS  Google Scholar 

  21. Hoge CW, Gambel JM, Srijan A, Pitarangsi C, Echeverria P. Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years. Clin Infect Dis. 1998;26(2):341–345

    Article  PubMed  CAS  Google Scholar 

  22. Paniker CK, Vimala KN. Transferable chloramphenicol resistance in Salmonella typhi. Nature. 1972;239(5367):109–110

    Article  PubMed  CAS  Google Scholar 

  23. Snyder MJ, Gonzalez O, Palomino C, et al. Comparative efficacy of chloramphenicol, ampicillin, and co-trimoxazole in the treatment of typhoid fever. Lancet. 1976;2(7996):1155–1157

    Article  PubMed  CAS  Google Scholar 

  24. Rowe B, Ward LR, Threlfall EJ. Multidrug-resistant Salmonella typhi: a worldwide epidemic. Clin Infect Dis. 1997;24 Suppl 1:S106–S109

    PubMed  Google Scholar 

  25. Wain J, Hoa NT, Chinh NT, et al. Quinolone-resistant Salmonella typhi in Vietnam: molecular basis of resistance and clinical response to treatment. Clin Infect Dis. 1997;25(6):1404–1410

    Article  PubMed  CAS  Google Scholar 

  26. Joshi S, Amarnath SK. Fluoroquinolone resistance in Salmonella typhi and S. paratyphi A in Bangalore, India. Trans R Soc Trop Med Hyg. 2007;101(3):308–310

    Article  PubMed  CAS  Google Scholar 

  27. Saha SK, Darmstadt GL, Baqui AH, et al. Molecular basis of resistance displayed by highly ciprofloxacin-resistant Salmonella enterica serovar Typhi in Bangladesh. J Clin Microbiol. 2006;44(10):3811–3813

    Article  PubMed  CAS  Google Scholar 

  28. Parry CM, Ho VA, Phuong le T, et al. Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin—azithro-mycin combination for treatment of multidrug-resistant and nali-dixic acid-resistant typhoid fever. Antimicrob Agents Chemother. 2007;51(3):819–825

    Article  PubMed  CAS  Google Scholar 

  29. Hirose K, Hashimoto A, Tamura K, et al. DNA sequence analysis of DNA gyrase and DNA topoisomerase IV quinolone resistance-determining regions of Salmonella enterica serovar Typhi and serovar Paratyphi A. Antimicrob Agents Chemother. 2002;46(10):3249–3252

    Article  PubMed  CAS  Google Scholar 

  30. Turner AK, Nair S, Wain J. The acquisition of full fluoroqui-nolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets. J Antimicrob Chemother. 2006;58(4):733–740

    Article  PubMed  CAS  Google Scholar 

  31. Ackers ML, Puhr ND, Tauxe RV, Mintz ED. Laboratory-based surveillance of Salmonella serotype Typhi infections in the United States: antimicrobial resistance on the rise. JAMA. 2000;283(20):2668–2673

    Article  PubMed  CAS  Google Scholar 

  32. Mermin JH, Townes JM, Gerber M, Dolan N, Mintz ED, Tauxe RV. Typhoid fever in the United States, 1985–1994: changing risks of international travel and increasing antimicrobial resistance. Arch Intern Med. 1998;158(6):633–638

    Article  PubMed  CAS  Google Scholar 

  33. Threlfall EJ, Fisher IS, Berghold C, et al. Trends in antimicrobial drug resistance in Salmonella enterica serotypes Typhi and Paratyphi A isolated in Europe, 1999–2001. Int J Antimicrob Agents. 2003;22(5):487–491

    Article  PubMed  CAS  Google Scholar 

  34. Gautam V, Gupta NK, Chaudhary U, Arora DR. Sensitivity pattern of Salmonella serotypes in Northern India. Braz J Infect Dis. 2002;6(6):281–287

    Article  PubMed  Google Scholar 

  35. Pokharel BM, Koirala J, Dahal RK, Mishra SK, Khadga PK, Tuladhar NR. Multidrug-resistant and extended-spectrum beta-lactamase (ESBL)-producing Salmonella enterica (serotypes Typhi and Paratyphi A) from blood isolates in Nepal: surveillance of resistance and a search for newer alternatives. Int J Infect Dis. 2006;10(6):434–438

    Article  PubMed  CAS  Google Scholar 

  36. Mandal S, Mandal MD, Pal NK. Antibiotic resistance of Salmonella enterica serovar Paratyphi A in India: emerging and reemerging problem. J Postgrad Med. 2006;52(3):163–166

    PubMed  Google Scholar 

  37. Heurtin-Le Corre C, Donnio P Y, Perrin M, Travert MF, Avril JL. Increasing incidence and comparison of nalidixic acid-resistant Salmonella enterica subsp. enterica serotype typhimurium isolates from humans and animals. J Clin Microbiol. 1999;37(1):266–269

    PubMed  CAS  Google Scholar 

  38. Malorny B, Schroeter A, Bunge C, Hoog B, Steinbeck A, Helmuth R. Evaluation of molecular typing methods for Salmonella enterica serovar Typhimurium DT104 isolated in Germany from healthy pigs. Vet Res. 2001;32(2):119–129

    Article  PubMed  CAS  Google Scholar 

  39. Prager R, Liesegang A, Rabsch W, et al. Clonal relationship of Salmonella enterica serovar typhimurium phage type DT104 in Germany and Austria. Zentralbl Bakteriol. 1999;289(4):399–414

    PubMed  CAS  Google Scholar 

  40. Fonseca EL, Mykytczuk OL, Asensi MD, et al. Clonality and antimicrobial resistance gene profiles of multidrug-resistant Salmonella enterica serovar infantis isolates from four public hospitals in Rio de Janeiro, Brazil. J Clin Microbiol. 2006;44(8):2767–2772

    Article  PubMed  CAS  Google Scholar 

  41. Liebana E, Garcia-Migura L, Clouting C, et al. Multiple genetic typing of Salmonella enterica serotype typhimurium isolates of different phage types (DT104, U302, DT204b, and DT49) from animals and humans in England, Wales, and Northern Ireland. J Clin Microbiol. 2002;40(12):4450–4456

    Article  PubMed  CAS  Google Scholar 

  42. Ghilardi AC, Tavechio AT, Fernandes SA. Antimicrobial susceptibility, phage types, and pulse types of Salmonella typhimurium, in Sao Paulo, Brazil. Mem Inst Oswaldo Cruz. 2006;101(3):281–286

    Article  PubMed  Google Scholar 

  43. Hakanen A, Kotilainen P, Huovinen P, Helenius H, Siitonen A. Reduced fluoroquinolone susceptibility in Salmonella enterica serotypes in travelers returning from Southeast Asia. Emerg Infect Dis. 2001;7(6):996–1003

    PubMed  CAS  Google Scholar 

  44. White DG, Zhao S, Sudler R, et al. The isolation of antibiotic-resistant salmonella from retail ground meats. N Engl J Med. 2001;345(16):1147–1154

    Article  PubMed  CAS  Google Scholar 

  45. Bager F, Helmuth R. Epidemiology of resistance to quinolones in Salmonella. Vet Res. 2001;32(3–4):285–290

    Article  PubMed  CAS  Google Scholar 

  46. Shahada F, Chuma T, Tobata T, Okamoto K, Sueyoshi M, Takase K. Molecular epidemiology of antimicrobial resistance among Salmonella enterica serovar Infantis from poultry in Kagoshima, Japan. Int J Antimicrob Agents. 2006;28(4):302–307

    Article  PubMed  CAS  Google Scholar 

  47. Musgrove MT, Jones DR, Northcutt JK, et al. Antimicrobial resistance in Salmonella and Escherichia coli isolated from commercial shell eggs. Poult Sci. 2006;85(9):1665–1669

    PubMed  CAS  Google Scholar 

  48. Glynn MK, Bopp C, Dewitt W, Dabney P, Mokhtar M, Angulo FJ. Emergence of multidrug-resistant Salmonella enterica serotype typhimurium DT104 infections in the United States. N Engl J Med. 1998;338(19):1333–1338

    Article  PubMed  CAS  Google Scholar 

  49. Quinn T, O'Mahony R, Baird AW, Drudy D, Whyte P, Fanning S. Multi-drug resistance in Salmonella enterica: efflux mechanisms and their relationships with the development of chromosomal resistance gene clusters. Curr Drug Targets. 2006;7(7):849–860

    Article  PubMed  CAS  Google Scholar 

  50. Gupta A, Fontana J, Crowe C, et al. Emergence of multidrug-resistant Salmonella enterica serotype Newport infections resistant to expanded-spectrum cephalosporins in the United States. J Infect Dis. 2003;188(11):1707–1716

    Article  PubMed  CAS  Google Scholar 

  51. Dunne EF, Fey PD, Kludt P, et al. Emergence of domestically acquired ceftriaxone-resistant Salmonella infections associated with AmpC beta-lactamase. JAMA. 2000;284(24):3151–3156

    Article  PubMed  CAS  Google Scholar 

  52. Spika JS, Waterman SH, Hoo GW, et al. Chloramphenicol-resistant Salmonella newport traced through hamburger to dairy farms. A major persisting source of human salmonellosis in California. N Engl J Med. 1987;316(10):565–570

    PubMed  CAS  Google Scholar 

  53. Varma JK, Marcus R, Stenzel SA, et al. Highly resistant Salmonella Newport-MDRAmpC transmitted through the domestic US food supply: a FoodNet case-control study of sporadic Salmonella Newport infections, 2002–2003. J Infect Dis. 2006;194(2):222–230

    Article  PubMed  CAS  Google Scholar 

  54. Helms M, Vastrup P, Gerner-Smidt P, Molbak K. Excess mortality associated with antimicrobial drug-resistant Salmonella typhimu-rium. Emerg Infect Dis. 2002;8(5):490–495

    PubMed  CAS  Google Scholar 

  55. Martin LJ, Fyfe M, Dore K, et al. Increased burden of illness associated with antimicrobial-resistant Salmonella enterica serotype typhimurium infections. J Infect Dis. 2004;189(3):377–384

    Article  PubMed  Google Scholar 

  56. Travers K, Barza M. Morbidity of infections caused by antimicrobial-resistant bacteria. Clin Infect Dis. 2002;34 Suppl 3:S131–S134

    Article  PubMed  Google Scholar 

  57. Wolday D, Erge W. Antimicrobial sensitivity pattern of Salmonella: comparison of isolates from HIV-infected and HIV-uninfected patients. Trop Doct. 1998;28(3):139–141

    PubMed  CAS  Google Scholar 

  58. Herikstad H, Hayes P, Mokhtar M, Fracaro ML, Threlfall EJ, Angulo FJ. Emerging quinolone-resistant Salmonella in the United States. Emerg Infect Dis. 1997;3(3):371–372

    Article  PubMed  CAS  Google Scholar 

  59. Kiessling CR, Cutting JH, Loftis M, Kiessling WM, Datta AR, Sofos JN. Antimicrobial resistance of food-related Salmonella isolates, 1999–2000. J Food Prot. 2002;65(4):603–608

    PubMed  CAS  Google Scholar 

  60. Bassily S, Hyams KC, el-Masry NA, et al. Short-course norfloxacin and trimethoprim-sulfamethoxazole treatment of shigellosis and salmonellosis in Egypt. Am J Trop Med Hyg. 1994;51(2):219–223

    PubMed  CAS  Google Scholar 

  61. Bennish ML, Salam MA, Khan WA, Khan AM. Treatment of shigellosis: III. Comparison of one- or two-dose ciprofloxacin with standard 5-day therapy. A randomized, blinded trial. Ann Intern Med. 1992;117(9):727–734

    PubMed  CAS  Google Scholar 

  62. Shanks GD, Smoak BL, Aleman GM, et al. Single dose of azithro-mycin or three-day course of ciprofloxacin as therapy for epidemic dysentery in Kenya. Acute Dysentery Study Group. Clin Infect Dis. 1999;29(4):942–943

    Article  PubMed  CAS  Google Scholar 

  63. Huang IF, Chiu CH, Wang MH, Wu CY, Hsieh KS, Chiou CC. Outbreak of dysentery associated with ceftriaxone-resistant Shigella sonnei: First report of plasmid-mediated CMY-2-type AmpC beta-lactamase resistance in S. sonnei. J Clin Microbiol. 2005;43(6):2608–2612

    Article  PubMed  CAS  Google Scholar 

  64. Jain SK, Gupta A, Glanz B, Dick J, Siberry GK. Antimicrobial-resistant Shigella sonnei: limited antimicrobial treatment options for children and challenges of interpreting in vitro azithromycin susceptibility. Pediatr Infect Dis J. 2005;24(6):494–497

    Article  PubMed  Google Scholar 

  65. Taneja N, Lyngdoh VW, Sharma M. Haemolytic uraemic syndrome due to ciprofloxacin-resistant Shigella dysenteriae serotype 1. J Med Microbiol. 2005;54(Pt 10):997–998

    Article  PubMed  Google Scholar 

  66. Bennish ML, Khan WA, Begum M, et al. Low risk of hemolytic uremic syndrome after early effective antimicrobial therapy for Shigella dysenteriae type 1 infection in Bangladesh. Clin Infect Dis. 2006;42(3):356–362

    Article  PubMed  CAS  Google Scholar 

  67. Girgis NI, Sultan Y, Hammad O, Farid Z. Comparison of the efficacy, safety and cost of cefixime, ceftriaxone and aztreonam in the treatment of multidrug-resistant Salmonella typhi septicemia in children. Pediatr Infect Dis J. 1995;14(7):603–605

    Article  PubMed  CAS  Google Scholar 

  68. Girgis NI, Tribble DR, Sultan Y, Farid Z. Short course chemotherapy with cefixime in children with multidrug-resistant Salmonella typhi septicaemia. J Trop Pediatr. 1995;41(6):364–365

    PubMed  CAS  Google Scholar 

  69. Neill MA, Opal SM, Heelan J, et al. Failure of ciprofloxacin to eradicate convalescent fecal excretion after acute salmonellosis: experience during an outbreak in health care workers. Ann Intern Med. 1991;114(3):195–199

    PubMed  CAS  Google Scholar 

  70. Sirinavin S, Thavornnunth J, Sakchainanont B, Bangtrakulnonth A, Chongthawonsatid S, Junumporn S. Norfloxacin and azithromycin for treatment of nontyphoidal salmonella carriers. Clin Infect Dis. 2003;37(5):685–691

    Article  PubMed  CAS  Google Scholar 

  71. Outbreaks of multidrug-resistant Shigella sonnei gastroenteritis associated with day care centers — Kansas, Kentucky, and Missouri, 2005. MMWR Morb Mortal Wkly Rep. 2006;55(39):1068–1071

    Google Scholar 

  72. Replogle ML, Fleming DW, Cieslak PR. Emergence of antimicrobial-resistant shigellosis in Oregon. Clin Infect Dis. 2000;30(3):515–519

    Article  PubMed  CAS  Google Scholar 

  73. Ashkenazi S, Levy I, Kazaronovski V, Samra Z. Growing antimicrobial resistance of Shigella isolates. J Antimicrob Chemother. 2003;51(2):427–429

    Article  PubMed  CAS  Google Scholar 

  74. Aysev AD, Guriz H. Drug resistance of Shigella strains isolated in Ankara, Turkey, 1993–1996. Scand J Infect Dis. 1998;30(4):351–353

    Article  PubMed  CAS  Google Scholar 

  75. Mates A, Eyny D, Philo S. Antimicrobial resistance trends in Shigella serogroups isolated in Israel, 1990–1995. Eur J Clin Microbiol Infect Dis. 2000;19(2):108–111

    Article  PubMed  CAS  Google Scholar 

  76. Ozmert EN, Gokturk B, Yurdakok K, Yalcin SS, Gur D. Shigella antibiotic resistance in central Turkey: comparison of the years 1987–1994 and 1995–2002. J Pediatr Gastroenterol Nutr. 2005;40(3):359–362

    Article  PubMed  Google Scholar 

  77. Vasilev V, Japheth R, Yishai R, Andorn N. Antimicrobial resistance of Shigella flexneri serotypes in Israel during a period of three years: 2000–2002. Epidemiol Infect. 2004;132(6):1049–1054

    Article  PubMed  CAS  Google Scholar 

  78. Carlson JR, Thornton SA, DuPont HL, West AH, Mathewson JJ. Comparative in vitro activities of ten antimicrobial agents against bacterial enteropathogens. Antimicrob Agents Chemother. 1983;24(4):509–513

    PubMed  CAS  Google Scholar 

  79. Flores A, Araque M, Vizcaya L. Multiresistant Shigella species isolated from pediatric patients with acute diarrheal disease. Am J Med Sci. 1998;316(6):379–384

    Article  PubMed  CAS  Google Scholar 

  80. Fulla N, Prado V, Duran C, Lagos R, Levine MM. Surveillance for antimicrobial resistance profiles among Shigella species isolated from a semirural community in the northern administrative area of santiago, Chile. Am J Trop Med Hyg. 2005;72(6):851–854

    PubMed  Google Scholar 

  81. Gomi H, Jiang ZD, Adachi JA, et al. In vitro antimicrobial susceptibility testing of bacterial enteropathogens causing traveler's diarrhea in four geographic regions. Antimicrob Agents Chemother. 2001;45(1):212–216

    Article  PubMed  CAS  Google Scholar 

  82. Isenbarger DW, Hoge CW, Srijan A, et al. Comparative antibiotic resistance of diarrheal pathogens from Vietnam and Thailand, 1996–1999. Emerg Infect Dis. 2002;8(2):175–180

    PubMed  CAS  Google Scholar 

  83. Jahan Y, Hossain A. Multiple drug-resistant Shigella dysenteriae type 1 in Rajbari district, Bangladesh. J Diarrhoeal Dis Res. 1997;15(1):17–20

    PubMed  CAS  Google Scholar 

  84. MoezArdalan K, Zali MR, Dallal MM, Hemami MR, Salmanzadeh-Ahrabi S. Prevalence and pattern of antimicrobial resistance of Shigella species among patients with acute diarrhoea in Karaj, Tehran, Iran. J Health Popul Nutr. 2003;21(2):96–102

    PubMed  Google Scholar 

  85. Tjaniadi P, Lesmana M, Subekti D, et al. Antimicrobial resistance of bacterial pathogens associated with diarrheal patients in Indonesia. Am J Trop Med Hyg. 2003;68(6):666–670

    PubMed  CAS  Google Scholar 

  86. Pazhani GP, Ramamurthy T, Mitra U, Bhattacharya SK, Niyogi SK. Species diversity and antimicrobial resistance of Shigella spp. isolated between 2001 and 2004 from hospitalized children with diarrhoea in Kolkata (Calcutta), India. Epidemiol Infect. 2005;133(6):1089–1095

    Article  PubMed  CAS  Google Scholar 

  87. Ahmed SF, Riddle MS, Wierzba TF, et al. Epidemiology and genetic characterization of Shigella flexneri strains isolated from three paediatric populations in Egypt (2000–2004). Epidemiol Infect. 2006;134(6):1237–1248

    Article  PubMed  CAS  Google Scholar 

  88. Iwalokun BA, Gbenle GO, Smith SI, Ogunledun A, Akinsinde KA, Omonigbehin EA. Epidemiology of shigellosis in Lagos, Nigeria: trends in antimicrobial resistance. J Health Popul Nutr. 2001;19(3):183–190

    PubMed  CAS  Google Scholar 

  89. Shapiro RL, Kumar L, Phillips-Howard P, et al. Antimicrobial-resistant bacterial diarrhea in rural western Kenya. J Infect Dis. 2001;183(11):1701–1704

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. St. Luke's Episcopal Hospital and Baylor College of Medicine, University of Texas — Houston School of Public Health, Houston, TX, USA

    Herbert L. DuPont

Authors
  1. Herbert L. DuPont
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Executive Vice President & Chief Medical Officer, Idenix Pharmaceuticals, Cambridge, MA, USA

    Douglas L. Mayers MD

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

DuPont, H.L. (2009). Antimicrobial Resistance of Shigella spp., Typhoid Salmonella and Nontyphoid Salmonella . In: Mayers, D.L. (eds) Antimicrobial Drug Resistance. Infectious Disease. Humana Press. https://doi.org/10.1007/978-1-60327-595-8_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-595-8_11

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60327-594-1

  • Online ISBN: 978-1-60327-595-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation